VALENCE TECHNOLOGY (VLNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : VALENCE TECHNOLOGY (VLNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mooter775 who wrote (19118)	4/9/2000 4:37:00 PM
From: Zeev Hed	Read Replies (2) of 27311

OTmooter, the blood substitute segment has sunk a lot of good capital in it. In the mid 70', Green Cross (A major Japanese outfit) had a family of oxygen bearing (dissolving) fluorocarbons under test, "ready to be marketed" and many other companies have continued on this path. ALLP is in essence continuing with improved formulations of those early "crude" compounds. One of the hidden problems with bovine derived substitute is the fear (maybe baseless) that pathogens much smaller than viruses (prions), could be transmitted into the blood supply. The problem with prios is that currently, you cannot detect them with any easy off the shelf test, you cannot even culture them, yet, some believe they are at the base of "Mad cow" disease and it some of its debilitating forms in humans. It will be an intereting story to follow. Zeev

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next